ANCO and UC San Francisco are collaborating on a Precision Oncology Symposium on November 9 at the Marines Memorial Club & Hotel in San Francisco. The Symposium is chaired by W. Michael Korn, MD, UC San Francisco. Precision oncology promises to improve the outcomes of patients through broad molecular diagnostic profiling and individualized treatment recommendations. Recent FDA approvals of new cancer treatments that are based on molecular tumor features and not disease type underscore the relevance of this approach. However, the landscape of available diagnostic technologies and targeted drugs is rapidly changing, making it extremely difficult for practicing oncologists and related professionals to stay up to date and to offer their patients the best molecular diagnostic approach possible. By attending this meeting, clinicians will be informed on cutting edge technologies and their optimal clinical application.

View syllabus